An elderly woman underwent ViV #TAVR for bioprosthetic valve dysfunction with high bilateral coronary obstruction risk. Simultaneous bileaflet modification and LLAMACORN modification enabled a successful outcome. https://t.co/Uz3rDSK52E #JACCCaseReports
Leaflet modification showed high technical feasibility but notable early clinical risk, supporting its use as an adjunctive strategy in carefully selected #TAVR patients. https://t.co/N9R8pSU8JA
#JACCINT@drgocchipinti@LaudaniClaudio@AnderRegueiro
Thanks to a large collaborative effort from 27 centers worldwide, we built the #LOFTER registry, collecting leaflet modification procedures to better understand procedural dynamics and outcomes of #leaflet#modification techniques to mitigate #coronary#obstruction in #TAVR patients.
We contributed to the dedicated issue on @JACCJournals, and results are available here.
https://t.co/Fm9yxtv8zR
More work ahead.
@AnderRegueiro
TAVITEANDO en el #ACISEC2026 🫀
Todo sobre TAVI: casos complejos, nuevas indicaciones y dos casos en VIVO desde Pamplona. Moderado por el Dr. José Raúl Moreno (La Paz) y el Dr. Victor Alfonso Jiménez Díez (Álvaro Cunqueiro).
#Hemodinamica#TAVI
Modificación de velos para evitar ocluir las coronarias: una de las maniobras más críticas del TAVI moderno. Dr. Ander Regueiro, Hospital Clínic de Barcelona.
#ACISEC2026#Hemodinamica
This State-of-the-Art review provides a comprehensive and practical overview of coronary interventions related to TAVI, encompassing coronary evaluation and physiological assessment, the indications and timing of percutaneous coronary intervention before and after valve implantation, and strategies for managing coronary obstruction. https://t.co/yojhLj5N5p
#EuroPCR 2⃣0⃣2⃣6⃣ Awards🏆: NAP best clinical case & abstract and PCR's Got Talent best abstract presentation
Congrats 👏 to Marina Poza Gonzalez 🇪🇸who received the Award for the best NAP clincal case presentation for "Management of left main occlusion while performing the TAVI BASILICA technique, a nursing perspective"
Congrats to👏Elizabeth Curtis 🇦🇺 who received the Best NAP Abstract Award for "Rethinking waste in the cardiac catheterisation laboratory"
And congrats 👏 to Marco Tagliafierro who received the PCR's Got Talent Best Abstract Award for "Nationwide long-term outcomes of aortic valve replacement in US dialysis patients: TAVI vs. surgical AVR"
Sincere congratulations to you and your teams!
@cvnurselin@Kelly_J_Victor@LinardosSpyros@elenikle@Columbia
#interventionalcardiology #science #cardiovascularresearch #cardiology
🔎 Discover next matchup for the Under40 ML CTO World Cup 2026!
Explore both cases and vote for the best one :
🇬🇧 Case 7:
Directed energy meets imaging precision.CT guided Electro-Cautery Assisted Re-entry (ECART) for ostial RCA CTO
Harsh Thakkar - From St George's University Hospital, United Kingdom
VS
🇪🇸 Case 8:
The re-entry GOAL: IVUS-Guided TD-ADR for Circumflex CTO
Guillermo Velazquez - From Hospital clinic Barcelona, Spain
💡Check out the presentation cases on our website and support the one you’d like to see live 👉https://t.co/HsvD1qNMui
⏳ It’s time to vote! You have 24 hours to make your choice between Case 7 and Case 8, until May 22nd at 12:00 PM! The case with the most votes will advance to the quarterfinals of the championship. ✅
🏆 For the final 4 semifinalists will present their cases on June 26th, 2026, during the ML CTO Course in Nice.
BATMAN was assoc w/ high technical success, effectiveness in preventing #LVOT obstruction, & appeared to be safe in ViR & ViV procedures. Adverse events were higher in ViMAC, according to an LBCT presented at #EuroPCR & simultaneously published in #JACCINT https://t.co/hHqTKZ7K1p
Finally out! Thank you to all the participating centers and operators!!
Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: BATMAN-Registry | JACC: Cardiovascular Interventions https://t.co/8oF6aF3VyI
Need to treat paravalvular leak? Our comprehensive review is now out in @CircIntv 💣
Huge thanks to @freixa_xavier for mentorship and to @ejfu0209 and all co-authors for their collaboration!
https://t.co/1awWUnR5M3
🫀 New PHYSTAVI pilot trial: LBBP is feasible for AV block after TAVI with preserved LVEF and shows midterm outcomes comparable to traditional RV apical pacing. This could influence how we approach pacing post-TAVI. Read more ⬇️
https://t.co/q0Pg1WNdWW
#CJCO#OpenAccess
🔥#PCRLV 2025 Top Late-Breaking Trial results: Managing patients with high thrombotic but also high bleeding risk is a persistent challenge.
Left atrial appendage occlusion (LAAO) reduces both thrombotic and bleeding risks in selected patients, however, how to manage the early post-procedure period has remained unclear.
1-year results of the ADALA Trial, presented by @freixa_xavier, in London, show that low-dose Apixaban may be a safer and more effective alternative to conventional therapy
PCR LONDON VALVE 2025 is about to start.
Excited to present in a session who @pedro_cepas is going to open, presenting 3-year results of the #LYTHEN trial.
Then, the floor is for the big @AnderRegueiro, presenting, for the first time, the preliminary results of the #LOFTER-TAVI registry - leaflet modification strategies to prevent coronary obstruction.
My presentation will focus on BASILICA performance in native vs valve-in-valve aortic interventions.
We are grateful to the people behind the 13 centres that have contributed to build this study/ies on.
See you in Westminster Room at 11.00
@hospitalclinic@UniBarcelona